Comparing minimal invasive extracorporeal circulation to conventional cardiopulmonary bypass in heart surgery
Official title: Minimally Invasive Extracorporeal Circulation Versus Conventional Cardiopulmonary Bypass in Patients Undergoing Cardiac Surgery (MiECS): a Randomised Controlled Trial
Run by Aristotle University Of Thessaloniki · NCT05487612 · Data updated 2026-11-12
This study is testing if a new heart surgery method called minimal invasive extracorporeal circulation can help patients avoid serious complications better than the traditional method.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 85 Years |
| Sex | All |
| Enrollment | 1300 (estimated) |
| Sponsor | Aristotle University Of Thessaloniki Academic / other |
| Locations | 13 sites (Toronto and 12 other locations) |
| Status | Recruiting |
| Started | May 26, 2022 |
| Main results expected | December 31, 2028 |
| Study ends | March 31, 2029 |
| Registry record updated | March 30, 2026 |
| Trial ID | NCT05487612 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients scheduled for elective or urgent coronary artery bypass grafting or aortic valve replacement who do not have contraindications for blood transfusions.
✕Probably not a fit
Patients requiring emergency surgery, major aortic surgery, or those with specific blood disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of minimal invasive extracorporeal circulation (MiECC) compared to conventional cardiopulmonary bypass (cCPB) in patients undergoing cardiac surgery, specifically coronary artery bypass grafting and aortic valve replacement. It aims to determine if MiECC can reduce serious postoperative complications such as death, myocardial infarction, and acute kidney injury. The trial is multicenter and randomized, involving several hospitals and led by a prominent research unit in Greece. The primary focus is on assessing the incidence of complications within 30 days post-surgery.
Why it matters
Potential benefit: If successful, this approach could significantly reduce postoperative complications and improve recovery outcomes for patients undergoing cardiac surgery.
How similar studies have gone: While previous studies on MiECC have been limited and varied in quality, this trial aims to provide robust evidence on its effectiveness compared to cCPB.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients undergoing any elective or urgent coronary artery bypass grafting (CABG), aortic valve replacement (AVR) or CABG+AVR surgery using extracorporeal circulation without circulatory arrest. Exclusion Criteria: * Requirement for emergency or salvage operation. * Requirement for major aortic surgery (e.g. aortic root replacement). * Contraindication or objection (e.g. Jehovah's Witnesses) to transfusion of blood products. * Congenital or acquired platelet, red cell or clotting disorders (patients with iron deficient anaemia will not be excluded). * Inability to give informed consent for the study (e.g. learning or language difficulties).
Where it's running
-
Perfusion Services University Health Network, Toronto General Hospital
Toronto, Canada Recruiting -
Cardiothoracic Department AHEPA University Hospital
Thessaloniki, Greece Recruiting -
Department of Cardiac Surgery GVM Anthea Hospital
Bari, Italy Recruiting -
Department of Cardiovascular Surgery, Izmir Bakırçay University, Faculty of Medicine
Izmir, Turkey (Türkiye) Recruiting -
Department of Cardiovascular Surgery, Faculty of Medicine, Recep Tayyip Erdoğan University
Rize, Turkey (Türkiye) Recruiting -
Department of Cardiac Surgery
Coswig, Germany Active not recruiting
Show 7 more locations
-
Department of Thoracic and Cardiovascular Surgery, University Medical Centre Goettingen
Göttingen, Germany Active not recruiting -
Department of Cardiothoracic and Vascular Surgery, Ulm University Hospital
Ulm, Germany Completed -
Department of Cardiac Surgery GVM Maria Eleonora Hospital
Palermo, Italy Active not recruiting -
Department of Cardiovascular Surgery, Ankara City Hospital
Ankara, Turkey (Türkiye) Active not recruiting -
Department of Cardiac Surgery, Royal Papworth Hospital
Cambridge, United Kingdom Active not recruiting -
Deparment of Cardiac Surgery, Castle Hill Hospital
Hull, United Kingdom Active not recruiting -
Department of Cardiothoracic Surgery, Hammersmith Hospital
London, United Kingdom Active not recruiting
Study contacts
- Study coordinator: Georgios Papazisis, Assoc. Prof.
- Email: papazisg@auth.gr
- Phone: +30 2310999323
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ultra-high-resolution cardiac CT with NAEOTOM Alpha before TAVI
This study will test whether ultra-high-resolution photon-counting CT can accurately detect coronary artery disease in patients having TAVI and potentially reduce the need for invasive coronary angiography.
-
Examining heart blood flow in patients with severe aortic valve narrowing
This study tests how two heart flow measurements can help doctors understand and treat patients with severe aortic valve narrowing and coronary artery disease.
-
A quick 10-minute heart scan for cardiac diseases
This study is testing a quick 10-minute heart scan to see if it can help diagnose heart problems better and faster for many patients without needing special dyes.
-
Personalized activity intervention for patients recovering from heart surgery
This study is testing whether a personalized activity program can help patients recovering from heart surgery feel better and recover faster compared to standard rehabilitation.
-
μFR-guided Drug-Coated Balloon Angioplasty vs Angiography-guided Angioplasty in Coronary Artery Disease
This trial tests whether using computational μFR guidance during drug-coated balloon angioplasty is better than standard angiography guidance for people with de novo coronary artery lesions.
-
Transcatheter Aortic Valve Replacement Registry for Outcomes and Quality Monitoring
This registry collects information from hospitals about patients undergoing TAVR to see how care and outcomes compare to guidelines and nationwide data.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.